share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  04/16 13:55
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on April 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Bourla's investment in the company, but without additional information, the impact on his total holdings remains unclear.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of the company's stock on April 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action reflects a change in Bourla's investment in the company, but without additional information, the impact on his total holdings remains unclear.
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於2024年4月15日執行了該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。該行動反映了Bourla對該公司的投資的變化,但如果沒有其他信息,對其總持股的影響尚不清楚。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於2024年4月15日執行了該公司股票的交易。公告中未披露該交易的具體細節,包括股票數量、股票性質、交易價格和股票總價值。該行動反映了Bourla對該公司的投資的變化,但如果沒有其他信息,對其總持股的影響尚不清楚。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息